{"DataElement":{"publicId":"3564082","version":"1","preferredName":"Chemotherapy Target Agent Prior Administered Type","preferredDefinition":"information related to the type of prior targeted agent chemotherapy administered","longName":"3564073v1.0:3564079v1.0","context":"SWOG","contextVersion":"1","DataElementConcept":{"publicId":"3564073","version":"1","preferredName":"Chemotherapy Target Agent Prior Administered","preferredDefinition":"information related to the prior administration of targeted agent chemotherapy","longName":"2404910v1.0:3564071v1.0","context":"SWOG","contextVersion":"1","ObjectClass":{"publicId":"2404910","version":"1","preferredName":"Chemotherapy","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04)","longName":"C15632","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0094ACAF-12DD-1BCA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-09-13","modifiedBy":"ONEDATA","dateModified":"2005-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3564071","version":"1","preferredName":"Target Agent Prior Administered","preferredDefinition":"The goal intended to be attained.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI):Earlier in time or order.:The act of having given something (e.g., a medication or test).","longName":"C25702:C1708:C25629:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Target","conceptCode":"C25702","definition":"An object fixed as a goal or point of examination; something to point at; a destination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C7CF9003-8F8A-BBBC-E040-BB89AD433BC5","latestVersionIndicator":"Yes","beginDate":"2012-08-21","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-08-21","modifiedBy":"ONEDATA","dateModified":"2012-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C7CF9003-8F9B-BBBC-E040-BB89AD433BC5","latestVersionIndicator":"Yes","beginDate":"2012-08-21","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-08-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"5/16/13 jc moved to SWOG context.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3564079","version":"1","preferredName":"Targeted Therapy Chemotherapy Type","preferredDefinition":"the type of chemotherapy treatment that uses drugs or other substances, such as monoclonal antibodies, to identify and attack specific cancer cells.","longName":"3564079v1.0","context":"SWOG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"mTOR inhibitor","valueDescription":"mTOR inhibitor","ValueMeaning":{"publicId":"3564080","version":"1","preferredName":"mTOR inhibitor","longName":"3564080","preferredDefinition":"mTOR inhibitor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C7CFF760-26AD-CD7D-E040-BB89AD433C77","latestVersionIndicator":"Yes","beginDate":"2012-08-21","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C7CFF760-26C6-CD7D-E040-BB89AD433C77","beginDate":"2012-08-21","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-08-21","modifiedBy":"ONEDATA","dateModified":"2012-08-21","deletedIndicator":"No"},{"value":"VEGF receptor inhibitor","valueDescription":"VEGF receptor inhibitor","ValueMeaning":{"publicId":"3564081","version":"1","preferredName":"VEGF receptor inhibitor","longName":"3564081","preferredDefinition":"VEGF receptor inhibitor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C7CFF760-26D0-CD7D-E040-BB89AD433C77","latestVersionIndicator":"Yes","beginDate":"2012-08-21","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-08-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C7CFF760-26E9-CD7D-E040-BB89AD433C77","beginDate":"2012-08-21","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-08-21","modifiedBy":"ONEDATA","dateModified":"2012-08-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3564078","version":"1","preferredName":"Targeted Therapy Chemotherapy Type","preferredDefinition":"A type of treatment that uses drugs or other substances, such as monoclonal antibodies, to identify and attack specific cancer cells. Targeted therapy may have fewer side effects than other types of cancer treatments.:The use of synthetic or naturally-occurring chemicals for the treatment of diseases.  Although this term may be used to describe any therapy involving the use of chemical-based agents, it is most commonly used to refer to the variety of chemical-based agents employed to treat cancer.  Cancer chemotherapy works by arresting or killing the growth and spread of cancer cells.  Because cancer cells usually divide much faster than normal cells, they are often very sensitive to the inhibitory actions of chemotherapeutic agents.  Chemotherapy may also include agents that enhance immune function or alter hormonal activity. (NCI04):Something distinguishable as an identifiable class based on common qualities.","longName":"C93352:C15632:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Targeted Therapy","conceptCode":"C93352","definition":"A type of cancer treatment that uses testing and medication to more precisely identify and treat cancer. These treatments target and disable genes or proteins necessary to the proliferation of cancer cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C7CFF760-2688-CD7D-E040-BB89AD433C77","latestVersionIndicator":"Yes","beginDate":"2012-08-21","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-08-21","modifiedBy":"ONEDATA","dateModified":"2012-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C7CFF760-2699-CD7D-E040-BB89AD433C77","latestVersionIndicator":"Yes","beginDate":"2012-08-21","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-08-21","modifiedBy":"CHILLIJ","dateModified":"2013-05-16","changeDescription":"5/16/13 jc moved to SWOG context.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Targeted agents","type":"Preferred Question Text","description":"Targeted agents","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"VEGF receptor inhibitor","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"mTOR inhibitor","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C7CFF760-26F3-CD7D-E040-BB89AD433C77","latestVersionIndicator":"Yes","beginDate":"2012-08-21","endDate":null,"createdBy":"KEARNSD","dateCreated":"2012-08-21","modifiedBy":"DWARZEL","dateModified":"2013-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}